United States Biotechnology & Medical Research

Coya Therapeutics Inc (COYA)

Track

Coya Therapeutics Inc. experienced notable insider buying activity in November 2024. Key executives, including the CEO, CFO, and Chief Medical Officer, executed multiple purchase transactions between November 11 and November 14, 2024. These acquisitions represent the most recent insider trading activity for the company, with no further transactions reported in the subsequent three-month period.
Ticker: COYA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Coya Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 14 Nov 2024
Value US$4,028,930.88 | Price 422.54 | Shares 21,850 (-18.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-14 B Purchase
3.4
SNYDER DAVID S

Chief Financial Officer

Officer
21,850 -18.8%
422.54
US$4,028,931 		21,850 -18.8% 422.54 US$4,028,931
2024-11-13 2024-11-13 B Purchase
1.1
Swaminathan Arun

Chief Executive Officer

Executive Director
53,382 -20.6%
177.98
US$388,878 		53,382 -20.6% 177.98 US$388,878
2024-11-12 2024-11-11 B Purchase
1.1
Swaminathan Arun

Chief Executive Officer

Executive Director
49,012 +30.1%
363.57
US$79,163 		49,012 +30.1% 363.57 US$79,163
2024-11-12 2024-11-11 B Purchase
0.8
Grossman Fred

Chief Medical Officer

Officer
2,710 +inf%
7.37
US$19,973 		2,710 +inf% 7.37 US$19,973
2024-03-05 2023-08-22 B Purchase
3.3
Lee Ann
Non-Executive Director
1,000 +6.1%
3.62
US$3,620 		1,000 +6.1% 3.62 US$3,620
2023-01-04 2023-01-03 B Purchase
Berman Howard

Chief Executive Officer

Executive Director Large shareholder
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
3.4
SNYDER DAVID S

Chief Financial Officer

Officer
7,000
0.00
US$0 		7,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Hepner Adrian

Chief Medical Officer

Officer
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
0.6
GOLDSTEIN DOV A MD
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Villalobos Anabella
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
3.3
Lee Ann
Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2023-01-04 2023-01-03 B Purchase
Garren Hideki
Non-Executive Director
2,000
0.00
US$0 		2,000 0.00 US$0
Explore more

More insider trading research around Coya Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America